When controlling for confounding variables such as age, tumor differentiation, tumor size, lymph node metastasis, depth of stromal infiltration, and FIGO staging, the multivariate analysis identified lymph node metastasis (HR = 1.76, 95% CI: 1.62-2.26, p = 0.001), FIGO staging (HR = 2.85, 95% CI: 1.73–4.16, p = 0.004), and Hec1 expression (HR = 2.79, 95% CI: 1.65–4.05, p = 0.012) as independent risk factors for overall survival rates (Table 3). The gene discussed is NDC80; the disease is metastatic malignant neoplasm in the lymph nodes.